Susquehanna International Group’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6763 |
|
|
2023
Q2 | – | Sell |
-11,031
| Closed | -$133K | – | 6837 |
|
|
2023
Q1 | $133K | Buy |
11,031
+3,341
| +43% | +$40.4K | ﹤0.01% | 5107 |
|
|
2022
Q4 | $35K | Sell |
7,690
-1,155
| -13% | -$5.26K | ﹤0.01% | 5256 |
|
|
2022
Q3 | $58K | Buy |
8,845
+3,793
| +75% | +$24.9K | ﹤0.01% | 5459 |
|
|
2022
Q2 | $55K | Buy |
5,052
+3,663
| +264% | +$39.9K | ﹤0.01% | 5214 |
|
|
2022
Q1 | $27K | Sell |
1,389
-1,928
| -58% | -$37.5K | ﹤0.01% | 5431 |
|
|
2021
Q4 | $119K | Buy |
3,317
+1,446
| +77% | +$51.9K | ﹤0.01% | 5223 |
|
|
2021
Q3 | $137K | Buy |
+1,871
| New | +$137K | ﹤0.01% | 4880 |
|